Skip to Main Content
Stephen Chung, M.D.

Stephen Chung, M.D.

Titles and Appointments

Assistant Professor

School
Medical School
Department
Internal Medicine | Children's Medical Center Research Institute at UT Southwestern
Graduate Programs
Cancer Biology

You have reached the Academic Profile.

For more information on the doctor and patient care, please visit the clinical profile.

  • Biography

    Stephen Chung, M.D., is an Assistant Professor in the Department of Internal Medicine at UT Southwestern Medical Center and a member of the Division of Hematology and Oncology, He is part of the Children’s Research Institute at UT Southwestern Medical Center.

    Originally from Highland Park, Illinois, Dr. Chung holds a bachelor's degree in biology and biochemistry from Cornell University in Ithaca, New York. He earned his medical degree at Washington University School of Medicine in St. Louis. He completed a residency in internal medicine at Massachusetts General Hospital in Boston followed by a medical oncology fellowship at Memorial Sloan Kettering Cancer Center in New York. As a postdoctoral fellow in the Human Oncology and Pathogenesis Program at MSKCC, Dr. Chung’s work led to the identification of the hematopoietic stem cell as the cell of origin for hairy cell leukemia, as well as the identification of CD99 as a disease stem cell marker and therapeutic target in cancer treatments.

    Certified by the American Board of Internal Medicine in medical oncology, Dr. Chung joined the UT Southwestern faculty in 2018.

    Dr. Chung’s laboratory research focuses on studying the molecular alterations in the hematopoietic (blood-forming) stem cells that underlie the development of AML and MDS. By studying these immature blood cells he aims to better understand what causes these diseases, as well as the mechanisms by which they sometimes become resistant to standard therapies. He is also interested in identifying novel alterations in cell surface protein expression in these diseases to identify new therapeutic targets and to develop new diagnostic tests. 

    Dr. Chung's clinical interest is the care of patients with clonal hematopoiesis, the myelodysplastic syndromes, and acute myeloid leukemia.

    Dr. Chung is a member of the American College of Physicians, the Dallas County Medical Society, the American Society of Clinical Oncology, the American Society of Hematology, and the International Society for Experimental Hematology.

  • Education
    Medical School
    Washington University School of Medicine (2006)
    Residency
    Massachusetts General Hospital (2009), Internal Medicine
    Fellowship
    Memorial Sloan-Kettering Cancer Center (2012), Medical Oncology
  • Research Interest
    • Acute Myeloid Leukemia
    • Clonal Hematopoiesis
    • Hematopoiesis
    • Leukemia Stem Cells
    • The Myelodysplastic Syndromes
  • Publications

    Star Featured Publications

    Featured Featured Featured Featured
    Real world efficacy of luspatercept in patients with lower-risk myelodysplastic syndromes/neoplasms (MDS); a single center study in a heavily pretreated cohort.
    Kometas ML, Hoff FW, Hyak J, Irizarry-Gatell V, Marinos Velarde A, Jackson C, Anderson J, Kalkan FN, Ramakrishnan Geethakumari P, Alvarenga Thiebaud J, Chen W, Weinberg OK, Cantu MD, Collins RH, Chung SS, Madanat YF, Leuk Lymphoma 2025 Mar 1-9
    CD44-Mediated Metabolic Rewiring is A Targetable Dependency of IDH-Mutant Leukemia.
    Lyu J, Liu Y, Liu N, Vu H, Cai F, Cao H, Kaphle P, Wu Z, Botten GA, Zhang Y, Wang J, Achyutuni S, Gao X, Iacobucci I, Mullighan CG, Chung SS, Ni M, DeBerardinis RJ, Xu J, Blood 2025 Jan
    RAS-mutant leukaemia stem cells drive clinical resistance to venetoclax.
    Sango J, Carcamo S, Sirenko M, Maiti A, Mansour H, Ulukaya G, Tomalin LE, Cruz-Rodriguez N, Wang T, Olszewska M, Olivier E, Jaud M, Nadorp B, Kroger B, Hu F, Silverman L, Chung SS, Wagenblast E, Chaligne R, Eisfeld AK, Demircioglu D, Landau DA, Lito P, Papaemmanuil E, DiNardo CD, Hasson D, Konopleva M, Papapetrou EP, Nature 2024 Oct
    Impact of the Affordable Care Act and Medicaid Expansion Among Patients With HIV-Associated Aggressive B-Cell Non-Hodgkin Lymphomas.
    Premnath N, Liu Y, Reves H, Pandey U, Nair RG, Anderson J, Afrough A, Anderson LD, Chung SS, Kaur G, Khan AM, Kumar KA, Madanat YF, Wolfe HR, Yilmaz E, Awan FT, Sweetenham J, Ramakrishnan Geethakumari P, JCO Oncol Pract 2024 Oct OP2400354
    Risk Prediction for Clonal Cytopenia: Multicenter Real-World Evidence.
    Xie Z, Komrokji RS, Al-Ali N, Regelson A, Geyer S, Patel AA, Saygin C, Zeidan AM, Bewersdorf JP, Mendez LM, Kishtagari A, Zeidner JF, Coombs CC, Madanat YF, Chung SS, Badar T, Foran JM, Desai P, Tsai C, Griffiths EA, Al Malki MM, Amanam I, Lai C, Deeg HJ, Ades L, Arana-Yi C, Osman AE, Dinner SN, Abaza Y, Taylor J, Chandhok NS, Soong D, Brunner AM, Carraway HE, Singh A, Elena C, Ferrari J, Galli A, Pozzi S, Padron E, Patnaik MM, Malcovati L, Savona MR, Al-Kali A, Blood 2024 Jul
    Racial and ethnic disparities in Acute Myeloid Leukemia: 15-year experience at a safety net hospital system.
    Dong S, Premnath N, Sadeghi N, Kainthla R, Chung SS, Collins RH, Li HC, Madanat YF, Leuk Res 2024 Apr 141 107503
  • Books

    Featured 

  • Honors & Awards
    • Individual Investigator Research Award
      Cancer Prevention Institute of Texas (2025)
    • R37 MERIT Award
      National Cancer Institute (2023)
    • Discovery Research Grant
      Evans MDS Foundation (2022)
    • Idea Development Award
      DoD Rare Cancers Research Program (2022)
    • Junior Faculty Scholar Award in Basic/Translational Research
      American Society of Hematology (2020-2022)
    • Cancer Prevention and Research Institute of Texas Scholar
      First time tenure-track faculty member (2018-2023)
    • Disease-Oriented Clinical Scholar
      UT Southwestern (2018-2021)
    • Clinical Scientist Research Career Development Award (K08)
      NCI (2017)
    • Paul Sherlock Housestaff Teaching Award
      MSKCC Department of Medicine (2017)
    • Fellow Scholar Award in Basic/Translational Research
      American Society of Hematology (2015-2017)
    • Postdoctoral Research Award
      Bone Marrow Failure Research Program, Department of Defense (2013-2015)
    • Young Investigator Award
      American Socity of Clinical Oncology (2012)
  • Professional Associations/Affiliations
    • American Society of Hematology (2009)
    • International Society for Experimental Hematology (2013)